Chinh Chu, who lead the 2016 $600 million CF Corporation, looking to file SPAC #2
U.S. News and World Report just released an article stating that Chinh Chu, a former Blackstone Group dealmaker, has partnered with Pinnacle Foods Chairman Roger Deromedi, for a new SPAC focused on the consumer sector.
The SPAC is reportedly expected later this year and Chu, Deromedi and Jason Giordano (another ex-Blackstone colleague on the team), have already hired investment banks. Deal size is rumored to be in the $500 million range.
This would be Chinh Chu’s second SPAC, following the $600 million CF Corp., which bought U.S. annuities and life insurer Fidelity & Guaranty Life in a deal worth around $1.84 billion.
You can read the full article here.
Any guesses as to which banks are going to underwrite this one? If CF Corp. is any indication, Citigroup, Credit Suisse and BofA were on the cover. Sounds like a nice line-up for SPAC #2.
FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...
At the SPAC of Dawn A new ripple is expected to come to the market today in the form of Ethereum spot ETFs after the SEC gave final approval to several yesterday. BlackRock, Fidelity, Bitwise, Franklin, and VanEck all received approval for their new funds and all but BlackRock plan to waive fees until they...